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REVIEW
Is treatment for bipolar disorder 
more effective earlier in illness course? A 
comprehensive literature review
Katie Joyce1, Andrew Thompson2,3 and Steven Marwaha2,4* 
Abstract 
Background: We aimed to investigate a key element of the early intervention approach whether treatment at an 
earlier stage of bipolar disorder is more effective than later in its course.
Methods: A comprehensive literature review using Medline, Embase, Psychinfo, PsycArticle, and Web of Science, 
as data sources, with a subsequent narrative synthesis. Study quality was assessed using the Cochrane risk of bias 
method.
Results: Our search strategy yielded eight primary papers and two meta-analyses (of psychological therapies and 
Olanzapine) in total representing 8942 patients. Five studies focused on comparisons between first and multiple 
episodes, and the others on fewer vs more episode categories. There was a consistent finding, suggesting treatment 
in earlier illness stage resulted in better outcomes in terms of response, relapse rate, time to recurrence, symptomatic 
recovery, remission, psychosocial functioning, and employment. This effect was found for pharmacological (Lithium, 
Olanzapine, Divalproex) and psychological treatments.
Limitations: There was high risk of selection, performance, and attrition bias in most studies. First admission or 
presentation is unlikely to equate to first episode, because of the duration of untreated illness. Some patients having 
experienced multiple episodes could be “treatment resistant”. Study heterogeneity precluded meta-analysis.
Conclusions: Psychological and pharmacological treatments in the early stages of illness are more effective than 
in the later stages of bipolar disorder across multiple domains. There is a first episode and the early phase effect. 
Consistent with the staging model of illness, findings provide evidence for the clinical utility of an early intervention 
approach in bipolar disorder to improve patient outcomes.
Keywords: Bipolar disorder, Early intervention, First episode, Effectiveness, Treatment, Multiple episodes
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
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Background
Mental illness causes considerable global disease burden, 
often affecting patients for their entire lifespan (Whit-
eford et al. 2013). Bipolar disorder, including subthresh-
old disorders, affect approximately 2 % of the population 
(Merikangas et al. 2011). It ranks as a major global cause 
of disability adjusted life years for 10–24 year olds (Gore 
et al. 2011), and people with the disorder are seven times 
more likely to die an unnatural death (Hayes et al. 2015). 
As well as the significant impact on public health, costs 
of the disorder are very high (Pari et  al. 2014), in part 
because of the functional losses associated with increas-
ing episode number (Marwaha et al. 2013).
Whilst many expert researchers (Berk et  al. 2009; 
Martin et al. 2013; Salvadore et al. 2008) have suggested 
early intervention (EI) could reduce the cumulative 
morbidity, early death and financial costs of bipolar dis-
order, for this case to be persuasive several pieces of evi-
dence need to align. Failure to make contact with mental 
health services and receive a prompt correct diagnosis 
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and initiation of treatment appear to be a problem for 
a range of mental disorders (Wang et al. 2005), but this 
appears particularly true for bipolar disorder. There are 
high levels of unmet need in young people with bipo-
lar disorder (Charney et  al. 2003). Delays in diagnosis 
are lengthy (mean 12.5 years), clinically important, and 
associated with social dysfunction (Matza et  al. 2005), 
as well as an increased risk of lifetime suicidality (Haw-
ton et al. 2005; Nery-Fernandes et al. 2012). Indeed, the 
delay in diagnosis risks young people receiving inap-
propriate treatment, which may worsen the condition. 
Thus, the early diagnosis and early initiation of treat-
ment appear important in bipolar disorder and this 
would support an EI approach.
If research identifies treatment is most effective earlier 
in illness course or soon after first episode, then a second 
and critical evidential strand would support the ration-
ale for EI in bipolar disorder. This would clearly demon-
strate that outcomes could be changed by having a focus 
early in the course of the disorder, thus moulding clinical 
treatment priorities. Such evidence is likely to support 
the further development and implementation of EI ser-
vices for people with bipolar disorder, consistent with the 
clinical staging approach to managing mental disorders 
(McGorry 2007).
Therefore, we aimed to review the extant literature, to 
investigate whether treatment at an earlier stage of bipo-
lar (e.g., after the first episode) is more effective than later 
in the course of the disorder.
Methods
A comprehensive review of the literature was completed. 
An initial scoping review enabled search terms to be 
selected and refined. This also allowed the development 
of predetermined inclusion and exclusion criteria for 
article selection to improve search strategy and to reduce 
bias in paper selection.
Sources of information
Using a systematic process, an extensive search of papers 
catalogued in Medline, Embase, Psychinfo, Psycarticle, 
and Web of Science was carried out in October 2015. 
Papers in the English language were searched, with no 
criterion for publication date. Following this, all abstracts 
were downloaded into the Endnote referencing system 
and duplicates were deleted. The inclusion and exclu-
sion criteria were applied to each abstract to create a 
list of papers for full-text retrieval. The reference lists of 
the included papers were examined for further papers, 
and the authors of the most relevant studies were con-
tacted requesting details of any other studies which they 
thought were important in the area.
Search terms
The search terms were arranged in groups and included 
mesh terms, (group 1); bipolar, or mania, or hypomania, 
or manic depression, AND (group 2); the early treatment, 
or treatment onset, or the early intervention, or first epi-
sode, or multiple episode, or incident, AND (group 3); 
outcome, or recovery, or relapse, or recurrence, or remis-
sion, NOT (group 4); and genetics, or surgery, or demen-
tia, or diabetes, or elderly or cardiovascular disease.
Inclusion and exclusion criteria
Inclusion criteria were: (a) patients diagnosed with bipo-
lar disorder (any type), (b) the direct comparison of 
outcome in the same study between treatment received 
earlier (including at first episode) with later in illness 
course. We also included studies which had sampled 
hospital inpatients and compared those earlier vs later 
in illness course. Exclusion criteria were: (a) non-English 
language papers, (b) studies in which the only population 
sampled were children, and (c) case-series data.
Data extraction
The full text of all included studies was scrutinised and a 
narrative synthesis completed directed at answering the 
research aims. Data were extracted on sample size, sam-
pling frame, study design, outcomes, and main results.
Results
The search generated 1311 abstracts, and after apply-
ing the inclusion and exclusion criteria, the full text of 
17 papers was retrieved. Seven full-text papers were 
excluded. The main reasons for study exclusion subse-
quent to full-text retrieval were either a lack of compari-
son with earlier or first episode (N = 3), or no comparison 
of treatment between groups (N = 2). On contacting rel-
evant authors, one author replied with three study sug-
gestions, one of which was already included and two 
that did not fulfil inclusion criteria. After reviewing the 
full-text studies, eight primary studies and two reviews 
were included for the final review. A PRISMA flowchart 
(Fig.  1) illustrates the number of studies included and 
excluded at each stage of the process. Table 1 shows the 
study characteristics and main findings. The total num-
ber of patients in reviewed studies was 8942. We do not 
present a meta-analytic synthesis of the studies due to 
heterogeneity and instead structure our findings narra-
tively, reviewing psychological or pharmacological treat-
ment and inpatient studies.
Study quality was appraised using the Cochrane risk of 
bias assessment (Higgins et al. 2008) and an overall view 
of the quality of the literature can be seen in Fig. 2. There 
was a high risk of selection, performance, and attrition 
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bias in most studies. However, in the main, studies dem-
onstrated a low risk of reporting bias, providing results 
for all outcomes that they measured.
Studies of psychological treatment
Colom et  al. (2010) investigated whether treatment 
response is affected by course of illness progression using 
the Kaplan–Meier survival analysis. They conducted a 
post-hoc sub analysis on 120 euthymic bipolar patients, 
assessing time to recurrence in patients undergoing 
group psychoeducation in relation to course of their 
illness. Patients who had experienced six episodes or less 
demonstrated a reduced time to recurrence (p =  0.038) 
from the addition of psychoeducation to treatment. 
Patients who had experienced more than seven episodes 
showed no significant difference in outcome by the addi-
tion of psychoeducation. In considering time spent ill, 
those who had experienced less than six episodes showed 
a reduction in time spent in any episode polarity with the 
psychoeducation treatment.
A meta-analysis of the effectiveness of psychologi-
cal therapies as adjuncts to usual pharmacotherapy was 
Fig. 1 Prisma flow chart
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completed by Scott et  al. (2007). Data were synthesized 
from nine studies examining cognitive behaviour ther-
apy, interpersonal social rhythms therapy, family focused 
therapy, and psychoeducation. Again, they found that 
adjuncts to treatment were less efficacious in preventing 
relapse if the patient had experienced more episodes. A 
significance difference emerged between relapse rates in 
patients who had experienced twelve episodes or less.
Studies of pharmacological treatment
Tohen et  al. (2010) conducted a two-year prospective 
observational study, comparing the efficacy of oral medi-
cation given after the first episode of mania with oral 
medication given after multiple episodes. The sample size 
was large (N = 3115). They also investigated the different 
characteristics of first episode and multiple episode bipo-
lar patients, assessing patients using the Young Mania 
Rating Scale (YMRS), Clinical Global Impressions-Bipo-
lar Disorder (CGI-BP) mania scores, CGI-BP depression, 
and the Hamilton Depression Rating Scale. Cox propor-
tional hazard modelling was used as the method of analy-
sis. During the study period, patients treated in their first 
episode not only reached recovery (anytime during study 
37.9 vs 32.0 %, end of 12 weeks 39.6 vs 33.1 %) or remis-
sion (first vs multiple episode 89.0 vs 81.4 %) more often, 
but they did so significantly more rapidly than patients 
treated in their later episode (p = 0.0126). Notably, this 
was despite patients in their first episode having higher 
mania ratings (YMRS) than multiple episode patients at 
baseline. It should be noted that some patients entered 
into this study were currently medicated (but requiring 
a change) and the findings refer to episode number as 
opposed to the duration of illness.
Using a double blind RCT design, Swann et al. (1999) 
investigated the effect of episode number on response to 
treatment in 154 inpatients with bipolar disorder. Par-
ticipants were randomly assigned to Divalproex, Lithium, 
or placebo medication. To investigate the effect of ill-
ness course on response to treatment, the number of the 
previous episodes was compared using improvement in 
the manic syndrome score from the Schedule for Affec-
tive Disorders and Schizophrenia (SADS) as the main 
outcome. An improved response to anti-manic medica-
tion was evident as measured by the SADS manic syn-
drome score in patients who had experienced fewer 
episodes. The pivotal point by which intervention must 
have been initiated to improve treatment response was 
approximately ten episodes.
These results are similar to the another investigation of 
the effect of illness stage on response to lithium proph-
ylaxis. Franchini et  al. (1999) sampled a mixed group 
of patients with mood disorders (N  =  270), but this 
included 171 people with bipolar disorder. They found 
that the earlier commencement of lithium prophylaxis 
(within the first 10 years of bipolar onset) was associated 
with improved treatment outcome as measured by recur-
rence rate of an affective episode even after adjustment 
for polarity, sex, age, onset, duration of illness, and dura-
tion of lithium prophylaxis. Furthermore, the significant 
association between treatment onset and outcome was 
stronger for ‘very early’ and ‘early’ lithium onset in com-
parison to the Lithium initiation after 11 years of preced-
ing illness. The results did not vary between those with 
recurrent depressive disorder and people with bipolar 
disorder and polarity of the illness did not mediate the 
impact of lithium on patient outcome.
A meta-analysis (Berk et  al. 2011) reviewed 12 ran-
domised control studies to examine the effect of illness 
staging on outcome in bipolar disorder with regard 
to treatment response with Olanzapine. Symptomatic 
response rates to treatment, as defined by >50 % reduc-
tion from baseline, were better in individuals who had 
experienced less than five episodes with response rate 
worsening after this point. There was a significant differ-
ence in the rates of response for those studies examining 
mania (52–69 % for <5 episodes vs 29–59 % for >5 epi-
sodes). On most outcome measures, the odds of respond-
ing were increased by a factor of two in those who had 
experienced less than five episodes.
The effect was less clear-cut for depression studies, in 
which rates of response were significantly higher for the 
1–5 episode group on only two measures. In terms of 
studies investigating maintenance treatment, relapse was 
reduced by 40–60 % for those who had experienced 1–5 
episodes or 6–10 episodes compared with the  >10 epi-
sode group with this being statistically significant with 
regard to relapse to mania only (p = 0.005).
Studies of hospital inpatient treatment
A number of hospital inpatient studies were identified 
as providing suitable data. Whilst these studies were 
not comparing a single treatment between groups, we 
0 2 4 6 8
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Fig. 2 Bar chart to show risk of bias in included studies
Page 6 of 9Joyce et al. Int J Bipolar Disord  (2016) 4:19 
equated hospital admission with hospital treatment. 
Whether the treatment was pharmacological and/or psy-
chological was not explicitly stated, but is likely to have 
involved both.
Sampling patients with bipolar disorder, Keck et  al. 
(1995) report that patients with multiple episodes 
(N = 37) required longer hospital stays to achieve recov-
ery in comparison to people with first episodes (N = 34). 
Furthermore, the increased requirement for treatment 
was despite similar ratings of illness severity on a vari-
ety of measures, including the YMRS, Hamilton Rating 
Scale for Depression, the Scale for Assessment of Posi-
tive Symptoms, and the Global Assessment Scale. The 
main limitation to the study was one of small sample 
sizes, though it is noteworthy that the participants were 
patients with severe symptoms by virtue of the sampling 
strategy.
Rosa et al. (2012) used a naturalistic design to investi-
gate the differences in psychosocial functioning in 119 
hospitalized bipolar patients comparing those experienc-
ing their first episode and multiple episodes. Significantly, 
more patients in the first-episode group had symptomatic 
recovery (vs multiple episodes) at 12  months (62.7 vs 
44.9 %, p = 0.005). Patients being treated in their first epi-
sode had better functional outcomes at 6 and 12 months 
compared with those being treated in later episodes in 
diverse outcomes, such as autonomy, occupation, cogni-
tion, interpersonal relationships, and leisure time even 
after controlling for the effects of age and affective symp-
toms at 12 months (all p < 0.005).
Dion et al. (1988) investigated the relationship between 
symptoms and functioning in patients with bipolar disor-
der (N = 67) admitted to hospital at a 6-month follow-up 
point. Comparing the first admission patients with those 
with one or more previous admissions, they found that 
the first admission group had a higher level of independ-
ent living at follow-up (85 vs 66 %). In terms of employ-
ment, the first admission group also fared better (66 vs 
33  %) assessed by the vocational status index, but in a 
multiple regression analysis, admission number did not 
predict employment status at 6 months.
Jiang (1999) conducted a prospective study investigat-
ing functional outcomes in 63 bipolar disorder patients 
who were admitted to hospital in Taiwan. In compari-
son to those who had experienced multiple admissions, 
the first admission group showed significantly higher 
vocational functioning (p = 0.034) and were more often 
employed (70 vs 31.8 %). Whilst more of the first admis-
sion group were living independently (70 vs 40 %) at year 
1, this was not statistically significant (p =  0.24). How-
ever, the number of admissions was not an independent 
predictor of vocational functioning after controlling for 
confounders using a regression analysis.
Discussion
Main findings
A comprehensive review of the current literature was 
completed to investigate whether the effectiveness of 
treatment of bipolar disorder varies depending on the ill-
ness stage. In summary, the literature suggests that treat-
ment earlier in the course of illness is more effective than 
in the later stages of bipolar disorder. Whilst being based 
on a small number of studies, this finding is seen for both 
psychological and pharmacological therapies and the 
effect is apparent in a range of functional, symptomatic, 
recurrence, and relapse outcome measures. When con-
founders were controlled, this effect was attenuated and 
rendered non-significant in two studies.
Limitations of the literature
There were several methodological limitations to the lit-
erature that frames our findings. We wished to answer 
the question of whether treatment is more effective ear-
lier in illness course. A suitable methodologically robust 
study design would be to sample treatment naïve individ-
uals with a first episode and multiple previous episodes 
of illness and compare treatment effectiveness between 
the groups. We did not identify any studies using this 
methodology.
A related point is that many of the identified studies 
included those with multiple episodes who had already 
received treatment within the previous episodes. A pro-
portion of these patients may have been “treatment 
resistant”, defined as having received two consecutive 
medications without recovery (Gitlin 2006). That group 
may have by definition, been less likely to respond to 
treatment in comparison to those with first episode and 
this could bias results in favour of treatment effectiveness 
earlier in illness course. In the main, it is unknown what 
proportion of the populations in these studies could be 
categorised as treatment resistant. However, in one study, 
approximately 50  % of the sample had previously found 
the treatment either ineffective or were intolerant to it 
(Bowden et al. 1994; Swann et al. 1999).
Studies from which relevant data could be extracted 
showed substantial variations in study design, sampling 
frames, analytic strategies, and outcomes measured. In 
addition, whilst nine studies used episode number as the 
category for comparison, one study reported length of ill-
ness (e.g., less than 10 years). Because of this heterogeneity 
in the literature, we did not statistically combine results in 
a meta-analysis, as in our judgement, this not feasible or 
considered potentially meaningful. Instead, we completed 
a narrative synthesis as the most methodologically sound 
way to understand the underlying patterns in the literature 
given the limitations described above. This type of synthe-
sis enabled a richer understanding of the extant literature.
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There may have been clinical and socio-demographic 
differences between the first and multiple episode 
groups, which could have had independent effects on 
outcome (Berk et  al. 2011; Tohen et  al. 2010) whether 
these were measured or not. Confounders, such as age, 
have been controlled for in some analyses and significant 
differences remain between the groups (Franchini et  al. 
1999; Rosa et  al. 2012). In other studies, despite strik-
ing absolute differences in outcome (e.g., employment) 
between the first and multiple admission groups, admis-
sion number did not remain significant after controlling 
for other factors (Jiang 1999). Variable adjustment for 
confounding and disparate analytic strategies (due to the 
nature of studies included) means that caution is needed 
in direct comparisons between studies.
How first episode was classified frequently relied on 
a first admission to hospital with four studies using the 
first admission as a proxy for first episode. This is impor-
tant given that prior to clinical diagnosis, patients have 
often experienced the previous affective symptoms (Mar-
tin et  al. 2013) and duration of untreated illness can be 
lengthy (Berk et al. 2007; Murru et al. 2015). This is the 
case even after presentation to mental health services 
(Patel et  al. 2015). There is a danger then in reviewing 
the literature that first episode status is conflated with 
the first admission or first contact with medical ser-
vices, when, in fact, this is not the case. This potential 
variation between studies means that caution should be 
exercised in conclusions, regarding episode number and 
treatment effectiveness. It is also difficult to make direct 
comparison between the bulks of studies that investigate 
the impact of episode number on treatment effectiveness 
with a study that details length of illness (Franchini et al. 
1999) as the variable analysed.
There were only five studies that compared people with 
first episode bipolar (with four relying on the first admis-
sion for this categorisation) and those with further epi-
sodes. Therefore, the current available literature (which 
included two meta-analyses) is weighted towards the 
comparisons of people who have already experienced a 
number of episodes with those having experienced more.
Finally, there may be a treatment confounding effect 
apparent in our results. For example, patients with the 
first episode bipolar disorder or in the early stages may 
have received more robust care than patients in com-
parison groups given the high priority now given globally 
to first episode mental disorders. This, of course, is less 
likely to be an issue for older studies.
Effectiveness of treatments in multiple domains
Psychological or pharmacological treatments at an ear-
lier stage of bipolar disorder are more effective that in 
the later stages. This is apparent in multiple domains 
covering outcomes of importance to both clinicians and 
patients. The literature spans greater effectiveness on 
relapse, remission, recovery rates, comorbidity, sympto-
matic and syndromal outcome, global psychosocial func-
tioning, and vocational and residential functioning. The 
fact that the same trend is seen with different treatment 
modalities, as well as a variety of outcomes adds validity 
and potency to our findings.
Timing
The evidence base in the first episode psychosis sug-
gests that using a stage-specific approach to treatment 
in first episode of illness is more effective than not (Mar-
shall et  al. 2011). The underlying tenet of this approach 
was supported by the current literature review. However, 
a number of studies, including the two meta-analyses, 
suggest even after a first episode, less episode number 
is associated with greater treatment effectiveness. This 
finding was independent of treatment studied (Lithium, 
Olanzapine, Divalproex, CBT, psychoeducation) or study 
design (Berk et  al. 2011; Colom et  al. 2010; Scott et  al. 
2007; Swann et al. 1999).
The pivotal point at which earlier treatment was more 
effective ranged from 5 to 12 episodes. Given the dif-
ferences between studies and the limitations of the lit-
erature, it is difficult to be sure that a pivotal episode 
number exists between this range after which effective-
ness changes or whether this is simply a function of how 
data were categorised and analysed. Further research is 
necessary to definitively answer this question.
The early treatment would seem important, but our 
findings suggest an early phase effect as opposed to a 
solely first episode effect. A possible interpretation is that 
for some people, it takes a number of episodes to achieve 
medication optimisation and adequate adherence and to 
be able to engage fully in therapy. Whilst the early inter-
vention services for bipolar disorder and their evaluation 
are in their infancy (Marwaha et al. 2016), evidence from 
an RCT sampling people early in illness course does sug-
gest that specialised and systematic treatment is more 
clinically and cost-effective than the standard outpatient 
care (Kessing et  al. 2013). The findings of this review 
would support an extension of this approach.
Why does treatment earlier in illness course improve 
outcomes?
The clinical staging approach for bipolar disorder sug-
gests a model, in which there is a progression from “at 
risk” symptoms to the first presentation, to multiple 
episodes right through to refractory illness (Kapczinski 
et  al. 2009). Movement through the stages can be due 
to a combination of genetic vulnerability, life stresses, 
and substance misuse, and each stage may be linked to 
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abnormalities in biomarkers, such as TNF-alpha, BDNF, 
and 3-nytrotyrosine (Kauer-Sant’Anna et  al. 2009). 
Advancing illness stage is associated with neuroprogres-
sion evidenced by the changes in the brain structure 
(especially in the fronto-limbic system) (Berk et al. 2011; 
Mwangi et al. 2016). Alongside these biological changes, 
there is evidence for a progressively smaller inter-episode 
period, as episode number increases. Whilst the earlier 
episodes may need to be triggered, the illness progresses 
episodes can begin to emerge spontaneously. This has 
been conceptualized into a stress sensitization-kindling 
model of bipolar disorder, in which repeated abnormal 
brain activity reduces the threshold for repeat events 
increasing the risk of relapse (Post 2007).
These factors are very likely to form part of the explana-
tion for our findings that treatment early in illness course is 
more effective than in later episodes in terms of both clini-
cal and symptomatic outcomes. This review suggests that 
the progression to later stages of illness is associated with 
treatments becoming less effective and these chimes with 
the requirement for more complex treatment regimes for 
many people who have well-established bipolar disorder 
(Post et  al. 2010). The greater effectiveness in improving 
functional outcomes in the early course may be particularly 
linked to the initial appearance and worsening of cognitive 
impairments with time, a factor which is known to inde-
pendently predict vocational functioning in bipolar disor-
der (Gilbert et al. 2013; Torres et al. 2011). Our findings also 
paradoxically highlight the scale of the therapeutic chal-
lenge to assist people in later stages of the illness, in which 
there appears to be some level of treatment resistance.
To conclude, this literature review found substantial 
evidence that both pharmacological and psychologi-
cal treatments for bipolar disorder are more effective in 
the earlier stages of illness. The effect, which is demon-
strable at the first episode, is also apparent in the early 
phases of treatment. The findings provide some evidence 
for the clinical and policy rationale of an early interven-
tion approach in bipolar disorder to improve patient 
outcomes.
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